These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23817999)

  • 1. Germinal center kinase-like kinase overexpression in T cells as a novel biomarker in rheumatoid arthritis.
    Chen YM; Chuang HC; Lin WC; Tsai CY; Wu CW; Gong NR; Hung WT; Lan TH; Lan JL; Tan TH; Chen DY
    Arthritis Rheum; 2013 Oct; 65(10):2573-82. PubMed ID: 23817999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis.
    Raptopoulou AP; Bertsias G; Makrygiannakis D; Verginis P; Kritikos I; Tzardi M; Klareskog L; Catrina AI; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2010 Jul; 62(7):1870-80. PubMed ID: 20506224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lectin-like oxidized low-density lipoprotein receptor 1 signal is a potent biomarker and therapeutic target for human rheumatoid arthritis.
    Ishikawa M; Ito H; Akiyoshi M; Kume N; Yoshitomi H; Mitsuoka H; Tanida S; Murata K; Shibuya H; Kasahara T; Kakino A; Fujita Y; Sawamura T; Yasuda T; Nakamura T
    Arthritis Rheum; 2012 Apr; 64(4):1024-34. PubMed ID: 22076918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
    Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH
    Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necessity of lysophosphatidic acid receptor 1 for development of arthritis.
    Miyabe Y; Miyabe C; Iwai Y; Takayasu A; Fukuda S; Yokoyama W; Nagai J; Jona M; Tokuhara Y; Ohkawa R; Albers HM; Ovaa H; Aoki J; Chun J; Yatomi Y; Ueda H; Miyasaka M; Miyasaka N; Nanki T
    Arthritis Rheum; 2013 Aug; 65(8):2037-47. PubMed ID: 23666827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
    Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP
    Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.
    Blaschke S; Schulz H; Schwarz G; Blaschke V; Müller GA; Reuss-Borst M
    J Rheumatol; 2001 Jan; 28(1):12-21. PubMed ID: 11196512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
    Pierer M; Brentano F; Rethage J; Wagner U; Hantzschel H; Gay RE; Gay S; Kyburz D
    Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disorders.
    Parolini O; Souza-Moreira L; O'Valle F; Magatti M; Hernandez-Cortes P; Gonzalez-Rey E; Delgado M
    Arthritis Rheumatol; 2014 Feb; 66(2):327-39. PubMed ID: 24504805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis.
    Waldburger JM; Palmer G; Seemayer C; Lamacchia C; Finckh A; Christofilopoulos P; Baeten D; Reith W; Gabay C
    Arthritis Rheum; 2011 Nov; 63(11):3354-63. PubMed ID: 21739421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of activation-induced, T cell-derived, and chemokine-related cytokine/lymphotactin and its functional role in rheumatoid arthritis.
    Blaschke S; Middel P; Dorner BG; Blaschke V; Hummel KM; Kroczek RA; Reich K; Benoehr P; Koziolek M; Müller GA
    Arthritis Rheum; 2003 Jul; 48(7):1858-72. PubMed ID: 12847680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.
    Ruth JH; Volin MV; Haines GK; Woodruff DC; Katschke KJ; Woods JM; Park CC; Morel JC; Koch AE
    Arthritis Rheum; 2001 Jul; 44(7):1568-81. PubMed ID: 11465708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble neuropilin-2, a nerve repellent receptor, is increased in rheumatoid arthritis synovium and aggravates sympathetic fiber repulsion and arthritis.
    Fassold A; Falk W; Anders S; Hirsch T; Mirsky VM; Straub RH
    Arthritis Rheum; 2009 Oct; 60(10):2892-901. PubMed ID: 19790074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 controls autoimmune arthritis via STAT-mediated regulation of the Th17 cell/Treg cell balance in mice.
    Park JS; Lim MA; Cho ML; Ryu JG; Moon YM; Jhun JY; Byun JK; Kim EK; Hwang SY; Ju JH; Kwok SK; Kim HY
    Arthritis Rheum; 2013 Apr; 65(4):949-59. PubMed ID: 23280308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin inhibition of miR-129-3p enhances IL-17 expression and monocyte migration in rheumatoid arthritis.
    Tsai CH; Liu SC; Wang YH; Su CM; Huang CC; Hsu CJ; Tang CH
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):15-22. PubMed ID: 27851983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
    Toh ML; Bonnefoy JY; Accart N; Cochin S; Pohle S; Haegel H; De Meyer M; Zemmour C; Preville X; Guillen C; Thioudellet C; Ancian P; Lux A; Sehnert B; Nimmerjahn F; Voll RE; Schett G
    Arthritis Rheumatol; 2014 Nov; 66(11):2989-3000. PubMed ID: 24623505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocarboxylate transporter 4, associated with the acidification of synovial fluid, is a novel therapeutic target for inflammatory arthritis.
    Fujii W; Kawahito Y; Nagahara H; Kukida Y; Seno T; Yamamoto A; Kohno M; Oda R; Taniguchi D; Fujiwara H; Ejima A; Kishida T; Mazda O; Ashihara E
    Arthritis Rheumatol; 2015 Nov; 67(11):2888-96. PubMed ID: 26213210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
    Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
    Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.
    Yudoh K; Matsuno H; Nakazawa F; Yonezawa T; Kimura T
    Arthritis Rheum; 2000 Mar; 43(3):617-27. PubMed ID: 10728756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and function of junctional adhesion molecule-C in human and experimental arthritis.
    Palmer G; Busso N; Aurrand-Lions M; Talabot-Ayer D; Chobaz-Péclat V; Zimmerli C; Hammel P; Imhof BA; Gabay C
    Arthritis Res Ther; 2007; 9(4):R65. PubMed ID: 17612407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.